This week in Washington IP news, the Senate Judiciary Committee will consider a series of bills that could limit pharmaceutical patent owners’ ability to enforce their patents against generic drug makers. Over in the House of Representatives, the House Science Committee will mark up a series of bills to support research and development as well as technology transfer and commercialization, while the House Europe Subcommittee will explore international case studies in offshore wind renewable energy innovation. Elsewhere, the American Enterprise Institute focuses on developments in the private commercial space sector, while the USPTO celebrates 75 years of the Lanham Act’s codification of U.S. trademark law this Tuesday.
Patent
- Enablement
- Fee Shifting
- Litigation
- Tillis to Garland/ Kanter: Pursuit of New Draft Policy on SEPs Shows a ‘Failure of innovation Leadership’
- Knowledge Ecology International’s New March-In Petition is Déjà vu All Over Again – With One Twist
- Property Rights Groups Urge Garland and Kanter to Withdraw ‘Misguided’ Policy Statement on SEPs Subject to FRAND
- CAFC Nixes District Court Claim Construction in Win for Firearms Patent Owner
- Tips for Litigating Multiple Simultaneous Patent Infringement Investigations at the ITC
Recent Posts
- Tillis to Garland/ Kanter: Pursuit of New Draft Policy on SEPs Shows a ‘Failure of innovation Leadership’
- Knowledge Ecology International’s New March-In Petition is Déjà vu All Over Again – With One Twist
- Property Rights Groups Urge Garland and Kanter to Withdraw ‘Misguided’ Policy Statement on SEPs Subject to FRAND
- CAFC Nixes District Court Claim Construction in Win for Firearms Patent Owner
- Tips for Litigating Multiple Simultaneous Patent Infringement Investigations at the ITC